Insider Trading
| SMTI Stock | USD 33.60 0.34 1.00% |
Under 61% of Sanara Medtech's investor base is looking to short. The analysis of overall sentiment of trading Sanara Medtech stock suggests that many investors are alarmed at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
Sanara |
Filed transaction by Sanara Medtech Director: . Insider Public Trading
Read at macroaxis.com
Sanara Medtech Fundamental Analysis
We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Sanara Medtech is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Sanara Medtech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
Peers
Sanara Medtech Related Equities
| NVST | Envista Holdings | 4.92 | ||||
| MLSS | Milestone Scientific | 4.12 | ||||
| INFU | InfuSystems Holdings | 4.12 | ||||
| LMAT | LeMaitre Vascular | 3.09 | ||||
| MHUA | Meihua International | 3.03 | ||||
| MMSI | Merit Medical | 2.95 | ||||
| PDEX | Pro Dex | 2.21 | ||||
| ATR | AptarGroup | 2.19 | ||||
| ANGO | AngioDynamics | 1.61 | ||||
| HAE | Haemonetics | 0.70 | ||||
| UTMD | Utah Medical | 0.40 | ||||
| KRMD | Repro Med | 0.36 | ||||
| DXR | Daxor | 2.16 | ||||
| POCI | Precision Optics, | 6.55 |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |